Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

180.59
Delayed Data
As of Mar 27
 +4.55 / +2.58%
Today’s Change
136.37
Today|||52-Week Range
203.30
-2.40%
Year-to-Date

Today’s Trading

Previous close176.04
Today’s open175.62
Day’s range175.44 - 183.00
Volume1,450,673
Average volume (3 months)1,282,673
Market cap$36.5B
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+13.57%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+46.49%
P/E ratio55.4
Price/Sales16.55
Price/Book10.89

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.25-0.40%
VRTXVertex Pharmaceutica...+2.74+2.33%
SHPGShire+2.47+1.04%
PRGOPerrigo Company PLC+1.65+1.00%
Data as of 4:02pm ET, 03/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.33
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Treasurer
Leonard Bell
Chief Operating Officer &
Director
David L. Hallal
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account